GAITHERSBURG, Md.--(BUSINESS WIRE)-- <\/p>\n
AccelPath, Inc. (ACLP) (AccelPath or the Company) announced today that the Company is working with three pathology laboratories in Texas. <\/p>\n
The three pathology laboratories are located near Houston, Texas. Interpretations for these laboratories are provided by the Company's interpretation partner, which has the exclusive rights to interpret all tissue pathology slides processed in these laboratories. In addition, the Company provides consulting services to the laboratories as they transition from non-digital, physical transportation of slides (to the interpretation partner) to eventually complete transmission of both slide and patient information digitally to remote reading site. These laboratories recognize the cost, logistical and other advantages of moving to digital transmission of pathology information and recognize that AccelPath provides the only available practical solution for digital telepathology. These laboratories provide AccelPath with an estimated initial total revenue base of approximately $250,000 per year. <\/p>\n
The Company has begun to install and use modules of its proprietary workflow software AccelSlideTM in these laboratories. Eventually, these laboratories will utilize AccelSlideTM fully to digitize the transport of patient records and digital slide images to reading centers anywhere in the United States and internationally. This workflow software continues to develop, improve and expand while being used by these laboratories. Also, they use AccelSlideTM, the laboratories provide valuable user feedback to the Company to further improve the workflow software. <\/p>\n
\"We believe that there are significant benefits to transitioning to digital pathology for our laboratory practice, stated Dr. RM. After our extensive research into digital telepathology solutions and service providers, we were convinced that AccelPath was the company that had the only viable digital solution. They currently provide us with remote pathology services through a very reputable institutional partner, while we utilize their workflow software solution to transition our practice to become fully digital. Our experience with the Company has been exemplary and we look forward to continuing our relationship. <\/p>\n
We are very pleased with our commercial and collaborative relationship with these three pathology laboratories, stated Shekhar Wadekar, AccelPaths Chairman and Chief Executive Officer. It is important to have customers who provide exclusive rights to their pathology, while assisting us improve AccelSlideTM with real-time feedback on our workflow software in addition to generating current revenues for the Company. We plan on expanding our product offerings in this region while we also continue to discuss other regional relationships both in the US and abroad. <\/p>\n
About AccelPath <\/p>\n
AccelPath provides technology solutions that play a key role in delivering information required for diagnosis of diseases and other pathologic conditions with and through its associated institutional pathologists. The medical institutions, with whom the Company partners, prepare comprehensive diagnostic reports of a patients condition and consult with referring physicians to help determine the most appropriate treatment. Such diagnostic reports enable the early detection of disease, allowing referring physicians to make informed and timely treatment decisions that improve their patients health in a cost-effective manner. The Company seeks out referring physicians and histology laboratories in need of high-quality pathology interpretations and manages HIPAA-compliant digital case delivery and reporting while developing comprehensive solutions for managing medical information. <\/p>\n
AccelPath is currently focused on the $14 billion anatomic pathology market in the US. The Companys business model builds upon the expertise of experienced pathologists to provide seamless, reliable and comprehensive pathology and special test offerings to referring physicians using conventional and digital technologies. The Company establishes longstanding relationships with the referring physicians as a result of focused delivery of its partners diagnostic services, personalized responses and frequent consultations, and its proprietary flexible information technology, or IT, solutions that are customizable to the referring physicians or laboratories as well as the pathologists needs. Such diagnostic reports often enable the early detection of disease, allowing referring physicians to make informed and timely treatment decisions that improve their patients health in a cost-effective manner. AccelPaths IT and communications platform enables it to efficiently and securely deliver diagnostic reports to referring physicians. In addition, AccelPaths IT platform enables close tracking and monitoring of medical statistics. <\/p>\n
AccelPath is focused on the design, research, development and integration of three-dimensional imaging devices and systems primarily in the healthcare industries which it contributes to the Company. The Company will also exploit its three-dimensional imaging technology for use in intelligent surveillance devices and systems, as well as three-dimensional facial recognition systems for security and law enforcement agencies through future strategic partnerships. Historically, the Companys largest customers have been the National Institutes of Health and the Department of Defense. <\/p>\n<\/p>\n
Read the original here: GAITHERSBURG, Md.--(BUSINESS WIRE)-- AccelPath, Inc. (ACLP) (AccelPath or the Company) announced today that the Company is working with three pathology laboratories in Texas Continue reading
\nAccelPath, Inc. Working with Three Pathology Laboratories<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"